Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-04-23 @ 9:23 PM
Study NCT ID:
NCT05565794
Status:
TERMINATED
Last Update Posted:
2025-04-13
First Post:
2022-09-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PEARLDIFER
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |